Danielle K Bulaon

Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication

Jared L. Johnson, O. Elemento, J. Blenis, 2022, Science Signaling.

Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity

J. Haidar, M. Kalos, S. Eastman, 2020, Cancer Immunology Research.

The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro

Jared L. Johnson, G. Getz, J. Blenis, 2020 .